Clinical Trials Browser

Phase 3 × ripretinib × Clear all

NCT03673501 2026-02-05

INTRIGUE

Phase 3 Active not recruiting

453 enrolled 20 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05734105 2025-12-17

INSIGHT

Phase 3 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03353753 2022-11-21

INVICTUS

Phase 3 Completed

129 enrolled 19 charts 2 FDA

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors